Ipath Series B Etf Current Valuation
GRN Etf | USD 27.45 0.45 1.61% |
Valuation analysis of iPath Series B helps investors to measure IPath Series' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that IPath Series' price fluctuation is very steady at this time. Calculation of the real value of iPath Series B is based on 3 months time horizon. Increasing IPath Series' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since IPath Series is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IPath Etf. However, IPath Series' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 27.45 | Real 27.1 | Hype 27.45 | Naive 27.71 |
The intrinsic value of IPath Series' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence IPath Series' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of iPath Series B helps investors to forecast how IPath etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IPath Series more accurately as focusing exclusively on IPath Series' fundamentals will not take into account other important factors: iPath Series B ETF Current Valuation Analysis
IPath Series' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, iPath Series B has a Current Valuation of 0.0. This indicator is about the same for the Barclays average (which is currently at 0.0) family and about the same as Commodities Focused (which currently averages 0.0) category. This indicator is about the same for all United States etfs average (which is currently at 0.0).
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
All Next | Launch Module |
IPath Fundamentals
Price To Earning | 3.36 X | |||
Number Of Employees | 28 | |||
Beta | 0.04 | |||
Total Asset | 122.13 M | |||
One Year Return | (9.70) % | |||
Three Year Return | (1.20) % | |||
Five Year Return | 22.90 % | |||
Net Asset | 122.13 M |
About IPath Series Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze iPath Series B's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IPath Series using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of iPath Series B based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with IPath Series
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IPath Series position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IPath Series will appreciate offsetting losses from the drop in the long position's value.Moving against IPath Etf
0.36 | SLV | iShares Silver Trust | PairCorr |
0.36 | SIVR | abrdn Physical Silver | PairCorr |
0.35 | GLTR | abrdn Physical Precious | PairCorr |
0.31 | GLD | SPDR Gold Shares | PairCorr |
0.31 | IAU | iShares Gold Trust | PairCorr |
The ability to find closely correlated positions to IPath Series could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IPath Series when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IPath Series - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling iPath Series B to buy it.
The correlation of IPath Series is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IPath Series moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if iPath Series B moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IPath Series can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out IPath Series Piotroski F Score and IPath Series Altman Z Score analysis. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.